What Is Apetamin Used For and Why Is It Illegal?

Apetamin is a syrup sold as a weight gain and appetite-boosting supplement, primarily marketed through social media and online retailers. Its active ingredient is cyproheptadine, a prescription antihistamine that increases hunger by blocking serotonin signaling in the brain’s appetite center. Apetamin is not approved for sale in the United States or the United Kingdom, and purchasing it carries real health risks.

How Apetamin Works

The key ingredient in Apetamin, cyproheptadine, was originally developed to treat allergies. It blocks histamine receptors (the same pathway targeted by allergy medications like Benadryl), but it also blocks serotonin receptors in the hypothalamus, the part of the brain that regulates hunger. Serotonin normally helps signal fullness. When that signal is suppressed, appetite increases.

In a randomized controlled trial of underweight children, those taking cyproheptadine went from eating about 3 meals per day to roughly 4 meals per day over four weeks. They gained an average of 0.60 kg (about 1.3 pounds) over eight weeks, compared to just 0.11 kg in the placebo group. BMI also rose significantly more in the treatment group. These are modest numbers under medical supervision, which is worth keeping in mind when evaluating the dramatic transformation claims common on social media.

What Cyproheptadine Is Actually Prescribed For

In a medical setting, cyproheptadine is a prescription drug with a narrow set of approved uses: seasonal and year-round allergies, hives, itching, and as a supportive treatment during severe allergic reactions. Everything else is off-label, meaning doctors sometimes prescribe it for conditions it wasn’t officially approved to treat.

Those off-label uses include appetite stimulation in people with anorexia nervosa or other forms of non-psychiatric appetite loss, migraine prevention, managing spasticity from spinal cord injuries, and treating sexual side effects caused by antidepressants. When prescribed for appetite, it’s typically given to people who are clinically underweight or losing weight due to a medical condition, and it’s monitored by a physician who can track side effects through bloodwork.

Why Apetamin Is Illegal in the U.S. and U.K.

The FDA classifies Apetamin as an illegally imported product. Because it contains cyproheptadine, it requires a prescription in the United States, and Apetamin has never gone through the approval process that would allow it to be legally marketed or sold. The FDA has specifically warned that consumers may not be aware of the serious side effects associated with cyproheptadine, or even how much of the drug a dose of Apetamin contains.

The situation is similar in the United Kingdom. The Medicines and Healthcare products Regulatory Agency considers Apetamin a medicinal product that requires a marketing authorization to be sold legally. No such authorization has ever been granted, making every sale of Apetamin in the U.K. a violation of medicines law. The agency has run public awareness campaigns warning about the risks of buying unregulated medicines online.

Despite this, Apetamin remains widely available through social media sellers, overseas pharmacies, and third-party marketplace listings. The product is manufactured in India and typically shipped internationally, bypassing the regulatory controls that exist for prescription medications.

Side Effects and Risks

Drowsiness is the most common side effect, and it can be significant. Cyproheptadine causes sedation, dizziness, and impaired coordination. For many users, this is noticeable enough to interfere with driving or daily activities, especially in the first days of use. Other frequent side effects include dry mouth, constipation, and blurred vision.

The more serious concern is liver damage. Cyproheptadine has been linked to liver injury that can develop within one to six weeks of starting the drug. In published case reports, Apetamin users have shown elevated liver enzymes, a marker of liver cell damage. One documented case involved a patient whose liver enzymes were elevated for over a year before the cause was traced to Apetamin use. Once the patient stopped taking it, enzyme levels dropped back toward normal, confirming the drug as the source. A case series identified 15 instances of liver injury potentially caused by cyproheptadine, with three patients developing a form of liver inflammation involving blocked bile flow.

The risk is compounded by the fact that Apetamin is unregulated. Without standardized manufacturing oversight, there’s no guarantee that each bottle contains a consistent or safe amount of cyproheptadine. Users are essentially dosing themselves with a prescription drug that has no quality control.

Severe Reactions and Overdose

At higher doses, cyproheptadine can cause serious neurological and cardiovascular effects. The FDA’s prescribing information for cyproheptadine lists the following possible adverse reactions:

  • Nervous system: confusion, hallucinations, tremor, convulsions, euphoria
  • Cardiovascular: low blood pressure, rapid heartbeat, irregular heart rhythm
  • Liver: hepatitis, liver failure, jaundice
  • Blood: destruction of red blood cells, dangerously low white blood cell counts
  • Respiratory: chest tightness, wheezing, thickened mucus in the airways

Overdose is particularly dangerous in children. The FDA warns that antihistamine overdose in infants and young children can cause hallucinations, central nervous system depression, seizures, and cardiac or respiratory arrest. Because Apetamin is sold without dosing guidance from a physician, the line between a “normal” dose and a harmful one is easy to cross, especially for smaller individuals.

Why People Use It Anyway

Apetamin gained popularity through social media, particularly among women seeking to gain weight in specific areas of the body for a curvier figure. Influencers and online sellers market it as a safe, natural-seeming supplement, often downplaying or ignoring its prescription drug status. The syrup format and vitamin-enriched branding make it look more like a health product than a medication.

The appeal is understandable. For people who struggle to gain weight, options can feel limited. But cyproheptadine increases appetite across the board. It doesn’t direct weight to specific body parts. Any weight gained will distribute according to your individual genetics and body composition, just as it would with any caloric surplus. The targeted curves shown in before-and-after photos often involve other interventions that aren’t disclosed.

For anyone genuinely struggling with low appetite or unintentional weight loss, cyproheptadine is available as a prescription medication in the U.S. under proper medical supervision. A doctor can evaluate whether it’s appropriate, start at a safe dose, and monitor liver function along the way. That path lacks the convenience of ordering a bottle online, but it also lacks the risk of taking an unregulated product with no quality assurance and no one tracking what it’s doing to your body.